| Asialoglycoprotein receptor mediated hepatocyte targeting—Strategies and applications AA D'Souza, PV Devarajan Journal of controlled release 203, 126-139, 2015 | 538 | 2015 |
| Polyethylene glycol–phosphatidylethanolamine conjugate (PEG–PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux RD Dabholkar, RM Sawant, DA Mongayt, PV Devarajan, VP Torchilin International journal of pharmaceutics 315 (1-2), 148-157, 2006 | 249 | 2006 |
| Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying PV Date, A Samad, PV Devarajan Aaps Pharmscitech 11, 304-313, 2010 | 141 | 2010 |
| Enhancing curcumin oral bioavailability through nanoformulations VS Ipar, A Dsouza, PV Devarajan European journal of drug metabolism and Pharmacokinetics 44, 459-480, 2019 | 135 | 2019 |
| Engineered nanocarriers of doxorubicin: a current update RR Patil, SA Guhagarkar, PV Devarajan Critical Reviews™ in Therapeutic Drug Carrier Systems 25 (1), 2008 | 133 | 2008 |
| Targeted drug delivery: concepts and design PV Devarajan, S Jain Springer International Publishing, 2015 | 116 | 2015 |
| Particle shape: a new design parameter for passive targeting in splenotropic drug delivery PV Devarajan, AB Jindal, RR Patil, F Mulla, RV Gaikwad, A Samad Journal of pharmaceutical sciences 99 (6), 2576-2581, 2010 | 111 | 2010 |
| Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma S Pranatharthiharan, MD Patel, VC Malshe, V Pujari, A Gorakshakar, ... Drug delivery 24 (1), 20-29, 2017 | 99 | 2017 |
| A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19 AS Lokhande, PV Devarajan European Journal of Pharmacology 891, 173748, 2021 | 97 | 2021 |
| Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers PV Devarajan, GS Sonavane Drug development and industrial pharmacy 33 (2), 101-111, 2007 | 96 | 2007 |
| Repurposing—a ray of hope in tackling extensively drug resistance in tuberculosis A Maitra, S Bates, T Kolvekar, PV Devarajan, JD Guzman, S Bhakta International Journal of Infectious Diseases 32, 50-55, 2015 | 93 | 2015 |
| Docosahexaenoic acid–mediated, targeted and sustained brain delivery of curcumin microemulsion RL Shinde, PV Devarajan Drug delivery 24 (1), 152-161, 2017 | 90 | 2017 |
| Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability DM Benival, PV Devarajan International journal of pharmaceutics 423 (2), 554-561, 2012 | 90 | 2012 |
| Nanoparticles of polyethylene sebacate: a new biodegradable polymer SA Guhagarkar, VC Malshe, PV Devarajan Aaps Pharmscitech 10, 935-942, 2009 | 87 | 2009 |
| Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: role of docosahexaenoic acid RL Shinde, GP Bharkad, PV Devarajan European Journal of Pharmaceutics and Biopharmaceutics 96, 363-379, 2015 | 83 | 2015 |
| Polyethylene sebacate–doxorubicin nanoparticles for hepatic targeting SA Guhagarkar, RV Gaikwad, A Samad, VC Malshe, PV Devarajan International journal of pharmaceutics 401 (1-2), 113-122, 2010 | 79 | 2010 |
| Insulin-loaded alginic acid nanoparticles for sublingual delivery NH Patil, PV Devarajan Drug delivery 23 (2), 429-436, 2016 | 74 | 2016 |
| Molecular dynamics simulation of drug uptake by polymer M Subashini, PV Devarajan, GS Sonavane, M Doble Journal of Molecular Modeling 17 (5), 1141-1147, 2011 | 73 | 2011 |
| HPTLC determination of ketorolac tromethamine PV Devarajan, SP Gore, SV Chavan Journal of pharmaceutical and biomedical analysis 22 (4), 679-683, 2000 | 70 | 2000 |
| Microemulsions and nanoemulsions for targeted drug delivery to the brain R L Shinde, A B Jindal, P V Devarajan Current Nanoscience 7 (1), 119-133, 2011 | 66 | 2011 |
